Oaktree Capital Management »

Travere Therapeutics shares owned by Oaktree Capital Management

Quarter-by-quarter ownership of Travere Therapeutics shares owned by Oaktree Capital Management from 13F filings

Historical chart of Oaktree Capital Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Oaktree Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Oaktree Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $10M 9.2M 1.13
2025-06-30 $7.4M 7.7M 0.96
2025-03-31 $7.2M 7.2M 1.00
2024-12-31 $11M 12M 0.96
2024-09-30 $26M 30M 0.86
2023-03-31 $1.5M 1.5M 0.98

More positions owned by Oaktree Capital Management

Torm Common Stock (TRMD)
Expand Energy Corp Common Stock (EXE)
Garrett Motion Common Stock (GTX)
Anglogold Ashanti Common Stock (AU)
Viper Energy Common Stock (VNOM)
State Street Corp Etf Put Option (SPY)
Talen Energy Corp Common Stock Call Option (TLN)
Telephone And Data Systems Common Stock (TDS)
Oracle Corp Common Stock Put Option (ORCL)
Sunopta Common Stock (STKL)
Core Scientific Common Stock (CORZ)
Barrick Mining Corp Common Stock (B)
Liberty Global Common Stock (LBTYA)
Ftai Aviation Common Stock (FTAI)
Cemex Sab De Cv Common Stock (CX)

View all positions for Oaktree Capital Management

Top funds holding Travere Therapeutics

Linden Advisors
D. E. Shaw & Co
Graham Capital Management
Advent Capital Management
Millennium Management
Lord, Abbett & Co
Point72 Asset Management
Oaktree Capital Management
Agf Management
Polar Capital Holdings
Affinity Asset Advisors
Henderson Group
Shenkman Capital Management
FMR
BlackRock

View all funds holding Travere Therapeutics